Answers are grounded in this paper and cite their sources.
(MRSA) requires sustainable alternatives. This study evaluates the multifunctional efficacy of green-synthesized, exopolysaccharide-mediated zinc oxide nanoparticles. EPS-ZnONP exhibited potent antibiofilm activity against S. aureus (MIC at 6 µg/ml; 20 mm inhibition zone at 10 µg/ml). SEM and fluorescence analysis elucidated strong antibiofilm potential revealing dense staphylococcal cell clusters in untreated samples while the treated samples showed biofilm eradication and cell shrinkage. Quorum sensing-associated virulence was markedly attenuated, showing a 24.9 ± 3.99% reduction in cell surface hydrophobicity at 100 μg/mL and strong inhibition of staphyloxanthin production. In Vigna radiata sprouts, EPS-ZnONPs boosted secondary metabolites and antioxidant capacity, peaking at 60 ppm with elevated total phenolics (2.27 ± 0.005 mg GAE/g), total flavonoids (7.46 ± 0.02 mg QE/g), saponins (0.486 mg/g), and DPPH radical scavenging (32.59 ± 0.04%). Primary metabolic reserves peaked distinctively, with carbohydrates reaching 128.6 ± 0.05 mg/g at 40 ppm and proteins hitting 0.79 ± 0.002 mg/g at 60 ppm. Biosafety assessments in zebrafish (Danio rerio) demonstrated enhanced growth kinetics and survival rates, alongside intact genomic DNA and RNA profiles confirming zero genotoxicity. Cytocompatibility was verified via MTT assay, retaining 92.7% viability in V79 fibroblasts (100 μg/mL) and 76.2% in A375 melanoma cells (50 μg/mL). These statistically significant (p < 0.05) outcomes validate EPS-ZnONPs as secure, multifunctional agents for biomedical and agricultural applications.
No takes yet. Share an insight, caveat, or question.
Nath et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: